Biogen Pharmachem Stock Performance
as on May 6, 2026 at 8:34 pm IST
Day's Low
Day's High
₹0.46₹0.48
2.13%
Downside
2.13%
Upside

52 Week's Low
52 Week's High
₹0.45₹1.08
4.26%
Downside
129.79%
Upside

Biogen Pharmachem share price movements today
- Previous Close
- ₹0.46
- Open
- ₹0.47
- Volume
- 30.33L
- Upper Circuit
- ₹0.55
- Lower Circuit
- ₹0.37
- Day's Low - High
- ₹0.46 - ₹0.48
- 52 Week Low - High
- ₹0.45 - ₹1.08
Biogen Pharmachem Historical Returns
- 1 Month Return
- -17.86 %
- 3 Month Return
- -33.33 %
- 1 Year Return
- -47.13 %
- 3 Year Return
- -34.29 %
- 5 Year Return
- + 91.67 %
Biogen Pharmachem Fundamentals
as on May 6, 2026 at 3:04 pm IST
Market Cap
₹30.52 Cr
Return on Equity (ROE)
-0.07
PE Ratio (TTM)
5.6
Return on capital employed (ROCE)
-0.07
Beta (LTM)
0P/B Ratio
5.88
Dividend Yield
0PEG Ratio
12.71
Quarterly Earnings Growth YOY
-248.39
EPS (TTM)
0Sector
Finance
Book Value
0Biogen Pharmachem Technical Analysis
Track how Biogen Pharmachem technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | |
CCI (20) | 74.07 | Neutral |
RSI (14) | 52.05 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 62.08 | Neutral |
Ultimate Oscillator (7,14,28) | 69.59 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 0.47 | Bullish |
EMA (20) | 0.47 | Bullish |
VWMA (20) | 0.47 | Bullish |
SMA (50) | 0.47 | Bullish |
EMA (50) | 0.47 | Bullish |
SMA (200) | 0.47 | Bullish |
EMA (200) | 0.47 | Bullish |
KAMA (200) | 0.47 | Bullish |
DEMA (200) | 0.47 | Bullish |
Biogen Pharmachem Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biogen Pharmachem with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 30.52 | 35.8% | 0.00 | -1 | NA | |
| NA | 492.32 | 18.71% | 0.51 | 31 | 54 | |
| NA | 95.22 | 12.82% | 0.53 | -18 | 48 | |
| NA | 415.90 | 939.73% | 0.50 | 9 | 27 | |
| NA | 298.45 | 86.72% | 0.53 | 2 | 11 |
Biogen Pharmachem Stock’s Investor Sentiment and Interest
Investment in Biogen Pharmachem Industries Ltd Shares on INDmoney has grown by 119.25% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:119.25% versus previous 30 day period
Search interest for Biogen Pharmachem Industries Ltd Stock has increased by 134% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:134% versus previous 30 day period
Biogen Pharmachem Industries Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Biogen Pharmachem Industries Ltd Annual Profit & Loss
Figures in Rupees Crores
Biogen Pharmachem Industries Ltd Cash Flow
Figures in Rupees Crores
Biogen Pharmachem Corporate Actions
View detailed summary of the earnings and dividend history of Biogen Pharmachem.
Biogen Pharmachem Industries Ltd Earnings Results
Biogen Pharmachem Industries Ltd’s net profit jumped 248.39% since last year same period to ₹0.46Cr in the Q3 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 193.88% jump in its net profits since last 3-months.
Read More about Earnings Results
Insights on Biogen Pharmachem Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 3 years, BSE Ltd has given 1986.2% return, outperforming this stock by 2020.5%
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 100.00% of holdings in Mar 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, BSE Ltd has given 79.0% return, outperforming this stock by 126.1%
NEGATIVE IMPACTPrice Dip

In the last 1 month, Biogen Pharma stock has moved down by -17.9%
About Biogen Pharmachem Industries Ltd
Revenue: ₹0.54Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.46Cr as on December 2025 (Q3 FY26)
Chairperson Name: Niraj Vaghela
| Organisation | Biogen Pharmachem Industries Ltd |
| Industry | Finance |
| CEO | Niraj Vaghela |
| E-voting on shares | Click here to vote |
FAQs
What is Biogen Pharmachem share price today?
Biogen Pharmachem share price today stands at ₹0.47 as on . Biogen Pharmachem share today touched a day high of ₹0.48 and a low of ₹0.46.
What is the 52 week high and 52 week low range for Biogen Pharmachem share?
Biogen Pharmachem touched a 52 week high of ₹1.08 and a 52 week low of ₹0.45. Biogen Pharmachem share price today i.e. is trending at ₹0.47, which is -56.48% down from its 52 week high and 4.44% up from its 52 week low.
What is Biogen Pharmachem's market capitalisation today?
Biogen Pharmachem market capitalisation is ₹41.52 Cr as on .
How to buy Biogen Pharmachem shares?
To buy Biogen Pharmachem shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 531752 or Biogen Pharmachem Industries Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Biogen Pharmachem shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Biogen Pharmachem trading volume today?
Biogen Pharmachem trading volume is 30.33L as on . This means that 30.33L shares of Biogen Pharmachem were bought and sold on the stock market during today's trading session.